Given that lipids and TGF-β1 are elevated in CKD [58, 59], we constructed an in vitro model similar to CKD by simultaneously stimulating HK-2 with TGF-β1 and palmitic acid (TPA). Here, TGFB1 is linked to chronic kidney disease.